INBX
Inhibrx Biosciences Inc.
$29.59
+$0.48(+1.67%)
42
Overall
--
Value
54
Tech
31
Quality
Market Cap
$400.09M
Volume
80.85K
52W Range
$10.81 - $28.73
Target Price
$12.00
Order:
Income Statement
| Metric | Trend | Chart | 2023 Dec | 2024 Dec |
|---|---|---|---|---|
| REVENUE | ||||
| Total Revenue | $1.6M | $200.0K | ||
| Total Revenue | $1.6M | $200.0K | ||
| GROSS PROFIT | ||||
| Gross Profit | $1.6M | $200.0K | ||
| OPERATING EXPENSES | ||||
| Operating Expenses | $155.0M | $331.6M | ||
| Research & Development | $130.1M | $203.7M | ||
| Research Expense | $130.1M | $203.7M | ||
| Selling, General & Administrative | $24.2M | $127.9M | ||
| General & Administrative Expenses | $24.2M | $127.9M | ||
| Depreciation & Amortization | -- | $2.3M | ||
| Depreciation & Amortization | -- | $2.3M | ||
| Other Operating Expenses | $580.0K | $3.4M | ||
| OPERATING INCOME | ||||
| Operating income | $-153.3M | $-331.4M | ||
| EBITDA | $-153.8M | $1.7B | ||
| NON-OPERATING ITEMS | ||||
| Interest Expense (Non-Operating) | -- | $13.5M | ||
| Gain on Sale of Securities | $-1.6M | -- | ||
| Other Income/Expense | $1.6M | $-2.0B | ||
| Other Special Charges | -- | $2.0B | ||
| PRE-TAX INCOME | ||||
| EBIT | $-155.0M | $1.7B | ||
| Pre-Tax Income | $-155.0M | $1.7B | ||
| INCOME TAX | ||||
| Tax Provision | $3.0K | $2.0K | ||
| NET INCOME | ||||
| Net Income | $-155.0M | $1.7B | ||
| Net Income (Continuing Operations) | $-155.0M | $1.7B | ||
| Net Income (Discontinued Operations) | $-155.0M | $1.7B | ||
| Net Income (Common Stockholders) | $-155.0M | $1.7B | ||
| Normalized Income | $-113.9M | $1.7B | ||
| TOTALS | ||||
| Total Expenses | $155.0M | $331.6M | ||
| SHARE & EPS DATA | ||||
| Average Shares Outstanding | $14.6M | $14.8M | ||
| Average Shares Outstanding (Diluted) | $14.6M | $15.0M | ||
| Shares Outstanding | $14.5M | $14.5M | ||
| Basic EPS | $-10.88 | $114.01 | ||
| Basic EPS (Continuing Operations) | $-10.88 | $114.01 | ||
| Diluted EPS | $-10.88 | $112.62 | ||
| Diluted EPS (Continuing Operations) | $-10.88 | $112.62 | ||
| OTHER METRICS | ||||
| Other Gand A | $24.2M | $127.9M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INBX | $29.59 | +1.7% | 80.85K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Inhibrx Biosciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW